1 Nov 2006
SFDA Announces New Rules on Re-examination of Drug Advertisements
The State Food and Drug Administration (SFDA) announced its provisional system for the re-examination of advertisements for drugs, medical equipment and health food on 11 October. From now on, advertisements for drugs, medical equipment and health food approved by local food and drug administrations must be re-examined by SFDA. Advertisements that fail the re-examination may not appear on the media.
Under the new system, provincial (district and city) food and drug administrations must examine advertisements for drugs, medical equipment and health food and be responsible for what they have examined and approved. Advertisements examined and approved by local food and drug administrations must be filed with SFDA for the record. The SFDA's Advertisement Examination and Supervision Office is responsible for supervising the work of advertisement examination by local food and drug administrations and will order the correction of advertisements that fail to meet the set criteria.
According to SFDA, in the event that the original examination organ disagrees with the correction order, SFDA will organise a re-examination of the advertisement whereby possible violations of relevant regulations will be checked. SFDA will establish an advertisement re-examiner database for this purpose, with members coming from SFDA's Drug Market Supervision Department and Advertisement Examination and Supervision Office as well as from among advertisement examiners at local drug administrations. The database will be managed by SFDA's Advertising Examination and Supervision Office. In case of substantial disagreement of opinions, the advice of experts, advertising supervision organs or consumers will be sought.